EcoDrugPlus

Cathepsin C

Ensembl ID : ENSSMAG00000019244
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSSMAG00000016710
Gene Symbol: CTSK
3 Cross references
222 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSSMAG00000016731
Gene Symbol: CTSS2.1
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSSMAG00000006857
Gene Symbol: CDC7
1 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSSMAG00000010065
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSSMAG00000017573
Gene Symbol: CHEK2
2 Cross references
205 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSSMAG00000026350
Gene Symbol: CCR9A
2 Cross references
188 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9b

Ensembl ID : ENSSMAG00000017090
Gene Symbol: CCR9B
2 Cross references
193 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSSMAG00000006793
Gene Symbol: CCKAR
1 Cross references
200 Possible Orthologues:

Cholecystokinin Receptor

Ensembl ID : ENSSMAG00000018535
Gene Symbol: LOC118320606
2 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSSMAG00000023020
Gene Symbol: LOC118309554
2 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSSMAG00000003961
Gene Symbol: LOC118290645
3 Cross references
258 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).